Kennedy Krieger Institute and Partek Incorporated Awarded $1.8M NIH Grant
News May 28, 2013
Partek Incorporated announced that in collaboration with the Kennedy Krieger Institute it has been awarded $1.8M by the National Institutes of Health (NIH) to develop commercial software to analyze human genetic changes that will illuminate chromosomal abnormalities that underlie conditions such as autism spectrum disorder (ASD), bipolar disorder, and schizophrenia.
Previously Partek and Kennedy Krieger collaborated to develop a novel mathematical method that combined two commonly used genotype association approaches to reveal the opaque genetic distinction between individuals. While that study focused on estimating the relatedness between populations, this study will leverage that research and narrow its focus to families with one or more members affected by ASD. This will facilitate the development of analysis tools to identify chromosomal abnormalities with the goal of identifying individuals with ASD during infancy. Earlier diagnosis will allow treatment to be started sooner when it can best improve life-long cognitive and social skills. These same analysis tools will be able to be used in the early diagnosis of mental health conditions including bipolar disorder and schizophrenia––potentially enabling early treatment. “One in every 88 children is diagnosed with an autism spectrum disorder and one in every four adults suffer from a diagnosable mental health disorder. We are excited to be working with researchers at Kennedy Krieger Institute to build tools that are innovative, rigorous, and useful to the biomedical research community.” said Tom Downey, Principal Investigator and President of Partek Incorporated.
Screening for Disease or Toxins in a Drop of BloodNews
Scientist have developed a multinozzle emitter array (MEA), a silicon chip that can dramatically shorten the time it takes to identify proteins, peptides, and other molecular components within small volumes of biological samples.READ MORE
Phenogenetic Map Created For Stem Cell Models Of Neurological DiseasesNews
Researchers at The Ohio State University Wexner Medical Center have performed the first meta-analysis of all induced pluripotent stem cell models for neurological and neurodegenerative diseases, and created an atlas of how cell characteristics are linked to their genotype.READ MORE
Diabetic Ketoacidosis Assay Collaboration Between Ortho Clinical Diagnostics and EKF DiagnosticsNews
EKF’s Beta-Hydroxybutyrate LiquiColor® Assay for detection of predominant ketone body now available on Ortho’s VITROS® 4600 Chemistry System and VITROS® 5600 Integrated System.READ MORE